DexCom, Inc. (DXCM) Earnings History
Growth Compounder23 years of earnings data (2003–2025) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
DexCom, Inc. (DXCM) Earnings Overview
As of July 8, 2026, DexCom, Inc. (DXCM) reported trailing twelve-month net income of $930M, reflecting +47.2% year-over-year growth. The company earned $2.36 per diluted share over the past four quarters, with a net profit margin of 17.9%.
Looking at the long-term picture, DXCM's 5-year EPS compound annual growth rate (CAGR) stands at +10.5%, showing solid earnings momentum. The company achieved its highest annual net income of $836M in fiscal 2025, representing a new all-time high.
DexCom, Inc. maintains industry-leading profitability with a gross margin of 60.0%, operating margin of 19.6%, and net margin of 17.9%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ABT ($6.28B net income, 14.7% margin), PODD ($303M net income, 9.1% margin), TNDM (-$95M net income, -20.2% margin), DXCM has outperformed on profitability metrics. Compare DXCM vs ABT →
DXCM Earnings vs Peers
Earnings metrics vs comparable public companies
DXCM Historical Earnings Data (2003–2025)
23 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $836M | +45.1% | $912M | $2.09 | 17.9% | 19.6% |
| 2024 | $576M | +6.4% | $600M | $1.42 | 14.3% | 14.9% |
| 2023 | $542M | +58.7% | $598M | $1.30 | 14.9% | 16.5% |
| 2022 | $341M | +57.3% | $391M | $0.80 | 11.7% | 13.4% |
| 2021 | $217M | -56.1% | $266M | $0.51 | 8.9% | 10.9% |
| 2020 | $494M | +388.2% | $300M | $1.27 | 25.6% | 15.5% |
| 2019 | $101M | +179.5% | $142M | $0.27 | 6.8% | 9.6% |
| 2018 | -$127M | -153.2% | -$186M | $-0.36 | -12.3% | -18.1% |
| 2017 | -$50M | +23.5% | -$43M | $-0.15 | -7.0% | -5.9% |
| 2016 | -$66M | -13.9% | -$64M | $-0.20 | -11.4% | -11.1% |
| 2015 | -$58M | -157.1% | -$57M | $-0.18 | -14.3% | -14.2% |
| 2014 | -$22M | +24.8% | -$22M | $-0.07 | -8.6% | -8.3% |
| 2013 | -$30M | +45.3% | -$29M | $-0.10 | -18.6% | -18.1% |
| 2012 | -$55M | -21.8% | -$56M | $-0.20 | -54.6% | -55.8% |
| 2011 | -$45M | +18.9% | -$45M | $-0.17 | -58.7% | -58.8% |
| 2010 | -$55M | -3.1% | -$45M | $-0.24 | -113.4% | -93.1% |
| 2009 | -$54M | +3.0% | -$46M | $-0.30 | -180.3% | -154.4% |
| 2008 | -$55M | -20.3% | -$53M | $-0.47 | -560.9% | -537.0% |
| 2007 | -$46M | +1.5% | -$47M | $-0.41 | -991.5% | -1008.8% |
| 2006 | -$47M | -51.5% | -$49M | $-0.43 | -2147.6% | -2273.0% |
| 2005 | -$31M | -120.6% | -$32M | $-0.41 | - | - |
| 2004 | -$14M | -40.7% | -$14M | $-1.53 | - | - |
| 2003 | -$10M | - | -$10M | $-1.14 | - | - |
Download Data
Export DXCM earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
23+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DXCM — Frequently Asked Questions
Quick answers to the most common questions about buying DXCM stock.
What is DXCM earnings per share (EPS)?
DXCM trailing twelve-month (TTM) diluted EPS is $2.36, reflecting +47.2% year-over-year growth. The 5-year EPS CAGR is +10.5%. Complete EPS history from 2003 to 2025 is available in the table on this page.
What is DexCom, Inc.'s net income?
DexCom, Inc. (DXCM) trailing twelve-month net income is $930M as of 2025. Earnings grew +47.2% year-over-year. DexCom, Inc. has been profitable for 7 consecutive years.
Is DXCM profitable?
Yes, DXCM is profitable with a TTM net income of $930M and a net profit margin of +17.9%. DexCom, Inc. has generated profits for 7 consecutive years.
What is DXCM's earnings growth rate?
DXCM compound annual EPS growth rates (CAGR): 1-Year: +47.2%, 3-Year: +37.7%, 5-Year: +10.5%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2003 to 2025.
What are DXCM's profit margins?
DexCom, Inc. net profit margin is +17.9%, operating margin is +19.6%, and gross margin is +60.0%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +34.5%.
Is DXCM growing earnings?
Yes, DXCM earnings are accelerating — EPS growth of +47.2% exceeds the 5-year CAGR of +10.5%. TTM net income reached $930M. Earnings momentum is strengthening.
What was DXCM's best earnings year?
DexCom, Inc.'s highest annual net income on record is $836M, achieved in fiscal year 2025. Earnings history on this page spans 2003 to 2025 and includes all annual and quarterly figures.
What were DXCM's earnings last quarter?
DXCM's most recent reported quarter was Q1 2026. Net income was $200M with diluted EPS of $0.51. For a full breakdown of all quarters, see the quarterly earnings table on this page.